Stock comparison
Medtronic
Medpace Holdings
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
MDT
Medtronic
Market cap
$97.84B
Sector
Healthcare
MEDP
Medpace Holdings
Market cap
$12.16B
Sector
Healthcare
Overall winner
Medpace Holdings MEDP
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | MDT | MEDP | Winner |
|---|---|---|---|
| Warren Buffett | 50C | 53C | MEDP |
| Benjamin Graham | 57C | 59C | MEDP |
| Philip Fisher | 44D | 62C | MEDP |
| Peter Lynch | 49D | 57C | MEDP |
| Joel Greenblatt | 33F | 72B | MEDP |
| Charlie Munger | 45D | 59C | MEDP |
| Terry Smith | 46D | 67B | MEDP |
Side-by-side metrics
| Metric | MDT | MEDP |
|---|---|---|
| Market cap | $97.84B | $12.16B |
| P/E (TTM) | 21.2x | 26.3x |
| EV/EBIT | 21.0x | 21.8x |
| ROIC (TTM) | 6.43% | 56.06% |
| Gross margin | 61.95% | 29.07% |
| Net margin | 13.0% | 17.19% |
| Revenue CAGR 5y | 2.73% | 21.99% |
| EPS CAGR 5y | 7.88% | 32.59% |
| Debt / Equity | 0.6x | 0.2x |
| Dividend yield | 3.73% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
MDT leads on
- Dividend yield3.73%vs 0.0%+100%
- Market cap$97.84Bvs $12.16B+88%
- Gross margin61.95%vs 29.07%+53%
- P/E (TTM)21.2xvs 26.3x+20%
MEDP leads on
- ROIC (TTM)56.06%vs 6.43%+89%
- Revenue CAGR 5y21.99%vs 2.73%+88%
- EPS CAGR 5y32.59%vs 7.88%+76%
- Debt / Equity0.2xvs 0.6x+57%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.